CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- 4 Open-market buy Director bought 5,000 shares at $6.01 ($30,050)
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale VP Clinical Development, CMO sold 4,000 shares at an average $7.00 ($28,001)
- 8-K Event Executive or director change
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- 4 Open-market sale VP Clinical Development, CMO sold 2,000 shares at $8.00 ($16,000)
- 4 Open-market sale VP Clinical Development, CMO sold 22,000 shares at an average $7.00 ($153,954)
- 4 Option exercise Director acquired 605 shares (option exercise)
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Material agreement · Other events
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- 8-K Event Regulation FD disclosure
- 8-K Event Other events
- 424B5 Offering Prospectus
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 27 of 34 · 678 filings